DUBLIN--(BUSINESS WIRE)--The "Isoflavones Market by Source (Soy, Red Clover), Application (Pharmaceuticals, Nutraceuticals, Cosmetics, and Food & Beverages), Form (Powder and Liquid), and Region (North America, Europe, Asia Pacific, RoW) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
The global isoflavones market is estimated to be valued at USD 1.1 billion in 2019 and is likely to reach USD 1.5 billion by 2025, growing at a CAGR of 4.7% during the forecast period.
Isoflavones are a phytoestrogen produced mainly by plants of the legume family, namely, soybeans, chickpeas, and red clover. They are potentially useful in lowering cholesterol, treating cancers and menopausal symptoms, maintaining bone health, and so on.
Growth in this market is mainly driven by the increasing incidences of chronic diseases, rising prevalence of cancer, technological advancements in the manufacturing of isoflavones, and the rapidly increasing geriatric population. However, stringent regulatory requirements and unfavourable drug price control policies across various countries are significant factors that are expected to restrain the growth of this market to a certain extent.
The soy segment in isoflavones market is estimated to account for the largest share in 2019.
Based on the source, the soy segment is estimated to account for the largest share in the isoflavones market in 2019. The segment is growing owing to factors such as nutritional and functional health-related properties since soy isoflavones are derived from soybeans and are particularly prevalent in soy germ. Genistein and daidzein are the major isoflavones present in soybean, which help in promoting overall health and wellness.
The pharmaceuticals segment in the isoflavones market is estimated to account for the largest share in 2019.
Based on the application, pharmaceuticals are estimated to account for the largest market share. The factors behind the growth is increasing the prevalence of diseases such as cancer, osteoporosis, and arthritis fuels the demand for isoflavones as they reduce the risk of the above-mentioned diseases and provide therapeutic effects.
The North American isoflavones market is projected to witness significant growth.
The North America region is projected to hold the major market share in the isoflavones market. It includes the US, Canada, Mexico. According to the United States Department of Agriculture, the US produced 341.62 million metric tons of soybean, Canada produced 7.72 million metric tons, and Mexico 0.43 million metric tons, in the year 2017-2018.
The region is one of the leading producers of soybeans, which creates ample opportunities for the manufacturing of isoflavones. Another factor propelling the growth of isoflavones in the region is rising obesity, which is a major concern among the youth, which is directing consumer focus toward a healthy lifestyle, thereby promoting their overall health and wellness.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
4.1 Attractive Opportunities in the Isoflavones Market
4.2 Isoflavones Market, By Region
4.3 Isoflavones Market, By Application
4.4 Asia Pacific: Isoflavones Market, By Source and Country
5 Market Overview
188.8.131.52 Rising Prevalence of Cancer and Cardiovascular Diseases
184.108.40.206 Rapidly Increasing Geriatric Population
220.127.116.11 Prevalence of Menopausal Issues
18.104.22.168 Growth in Demand for Fortified Food Owing to the Increasing Health-Consciousness Amongst Consumers
22.214.171.124 Stringent Regulatory Requirements
126.96.36.199 Emerging Markets
188.8.131.52 Emerging Technologies
184.108.40.206 Less Efficiency Compared to Alternatives
5.2 Adjacent Economies - Market Size (Historical/Forecast)
5.3 YC & YCC Shift
6 Isoflavones Market, By Source
6.2.1 Owing to the Nutritional and Functional Health-Related Properties, the Soy Segment is Projected to Dominate the Isoflavones Market
6.3 Red Clover
6.3.1 The Wide Applications of Red Clover in Applications Such as Food & Beverages, Pharmaceuticals, and Nutraceuticals to Drive the Demand
7 Isoflavones Market, By Application
7.5 Food & Beverages
8 Isoflavones Market, By Form
8.2.1 Owing to Factors Such as Convenience in Handling, Powdered Isoflavones in Pharmaceutical and Nutraceutical Industries to Witness High Demand
8.3.1 Demand for Liquid Isoflavones From Cosmetic and Nutraceutical Industries to Fuel the Market
9 Isoflavones Market, By Region
9.2 North America
220.127.116.11 Rise in Cardiovascular Diseases and Menopausal Issues to Drive the Isoflavones Market
18.104.22.168 Well-Established and Constantly Growing Pharmaceuticals Market to Drive the Growth
22.214.171.124 Growing Demand for Supplements With Natural Ingredients to Drive the Growth
126.96.36.199 Growing Pharmaceutical Industry With Rising R&D Investment
188.8.131.52 Growing Pharmaceutical and Nutraceutical Industry to Drive the Growth
184.108.40.206 Rise in Sales of Beauty Cosmetic Products as Well as Growing Pharmaceutical Industry to Drive the Demand
220.127.116.11 Rise in Investments in Pharmaceutical Therapeutics to Drive the Market
18.104.22.168 Rising Consumption of Supplement to Drive the Market
9.3.6 Rest of Europe
9.4 Asia Pacific
22.214.171.124 Growing Incidences of Chronic Diseases to Drive the Market
126.96.36.199 Growing Aging Population to Opt for Isoflavone Nutraceutical Supplement
188.8.131.52 Growing Instances of Chronic Diseases to Drive the Market
9.4.4 Rest of Asia Pacific
9.5.1 South America
184.108.40.206 Growing Nutraceutical, and Functional Food & Beverages Market to Drive the Isoflavone Market
9.5.2 Middle East & Africa
220.127.116.11 Growing Lifestyle-Related Health Concerns, Such as Obesity, and Heart Diseases Market to Drive the Isoflavone Market
10 Competitive Landscape
10.2 Competitive Leadership Mapping (Overall Market)
10.2.1.1 Visionary Leaders
10.2.1.3 Dynamic Differentiators
10.2.1.4 Emerging Companies
10.3 Ranking of Key Players, 2018
11 Company Profiles
11.3 International Flavors and Fragrances (Frutarom)
11.6 Nexira Inc.
11.7 Shanghai Freemen
11.8 SK Bioland
11.1 Avestia Pharma
11.11 Nutrascience Labs
11.12 Tradichem S.L
11.13 Nutra Green Biotechnology
11.14 Herbo Nutra
11.15 Futureceuticals Inc.
11.16 Bio-Gen Extracts Pvt. Ltd
11.17 Xena Bio Herbals Pvt Ltd.
11.18 Sikko Industries Ltd.
11.19 Shaanxi Hongda Phytochemistry Co Ltd
For more information about this report visit https://www.researchandmarkets.com/r/6pfd0s